Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2011-05-09 17:18:25
Reporting Period:
Filing Date:
Accepted Time:
2011-05-09 17:18:25
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
786947 Acura Pharmaceuticals Inc ACUR Pharmaceutical Preparations (2834) 110853640
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1058352 G William Skelly C/o Acura Pharmaceuticals, Inc.
616 N. North Court
Palatine IL 60067
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stiock Disposition 2011-05-09 5,000 $4.27 90,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
  1. Amount of securities include 75,000 remaining Restricted Stock Units held by Reporting Person. Absent a change of control, shares of common stock will be distributed in exchange for Restricted Stock Units (after payment of $.01 par value per share) in three equal installments on January 1st of each of 2012, 2013 and 2014.